Answers are grounded in this paper and cite their sources.
In an article published in Current Drug Targets - Inflammation and Allergy in December 2002, I had reviewed the critical role played by inflammatory mediators in the pathogenesis of acute pancreatitis and associated multiple organ dysfunction syndrome (MODS) and the potential for these mediators as therapeutic targets. Recent work, by us as well as other investigators, has further substantiated a potential for these mediators as therapeutic targets for this condition.
No takes yet. Share an insight, caveat, or question.
Madhav Bhatia (2004) studied this question.
Synapse has enriched 6 related papers. Consider them for comparative context: